Literature DB >> 27364632

Pacific Island Pharmacovigilance: The Need for a Different Approach.

John McEwen1, Lasse S Vestergaard2,3,4, Amanda L C Sanburg5.   

Abstract

Many Pacific Island countries (PICs) are recipients of funding support from the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). However, most of these countries cannot be expected to meet Global Fund and World Health Organization (WHO) minimum requirements for a functioning pharmacovigilance (PV) system. We argue that a different approach is required to move PV forward in such countries. Although the long-term aim is to build adequate national PV capacity, we propose an approach in which resources are focused initially towards ensuring a proper system for the reporting of "problems with medicines" such as substandard and counterfeit products. The limited health system resources in these countries require that PV will be supported by some of the organizations also giving funding aid for the supply of medicines.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27364632     DOI: 10.1007/s40264-016-0439-4

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  4 in total

1.  National policies for safety of medicines in the Asia Pacific region.

Authors:  Socorro Escalante; John McEwen
Journal:  WHO South East Asia J Public Health       Date:  2013 Apr-Jun

2.  The Global Fund and pharmacovigilance systems in resource-limited settings.

Authors:  S Xueref; J Daviaud; S Pal
Journal:  Lancet       Date:  2013-04-20       Impact factor: 79.321

3.  The Vanuatu medical supply system - documenting opportunities and challenges to meet the Millennium Development Goals.

Authors:  Andrew Brown; Ben Gilbert
Journal:  South Med Rev       Date:  2012-07-23

4.  Quality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chain.

Authors:  Manuel W Hetzel; Madhu Page-Sharp; Nancy Bala; Justin Pulford; Inoni Betuela; Timothy M E Davis; Evelyn K Lavu
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.